UniProt ID | Protein Name | Gene Symbol ▼ | No. of Glycosylation Sites | No. of GlyTouCan IDs | Disease Ontology |
---|---|---|---|---|---|
Q9H2C0 | Gigaxonin |
|
9 | 1 |
|
O60755 | Galanin receptor type 3 |
|
1 | 0 |
|
O43603 | Galanin receptor type 2 |
|
2 | 0 |
|
P47211 | Galanin receptor type 1 |
|
3 | 0 |
|
Q49A17 | Polypeptide N-acetylgalactosaminyltransferase-like 6 |
|
2 | 0 |
|
Q7Z4T8 | Inactive polypeptide N-acetylgalactosaminyltransferase-like protein 5 |
|
1 | 0 |
|
Q9HCQ5 | Polypeptide N-acetylgalactosaminyltransferase 9 |
|
1 | 0 |
|
Q9NY28 | Probable polypeptide N-acetylgalactosaminyltransferase 8 |
|
3 | 0 |
|
Q86SF2 | N-acetylgalactosaminyltransferase 7 |
|
2 | 2 |
|
Q8NCL4 | Polypeptide N-acetylgalactosaminyltransferase 6 |
|
8 | 1 |
|
A5PL16 | GALNT5 protein |
|
2 | 0 |
|
Q7Z7M9 | Polypeptide N-acetylgalactosaminyltransferase 5 |
|
65 | 4 |
|
Q68VJ5 | Polypeptide N-acetylgalactosaminyltransferase 5 (Fragment) |
|
1 | 0 |
|
Q8N4A0 | Polypeptide N-acetylgalactosaminyltransferase 4 |
|
2 | 2 |
|
Q14435 | Polypeptide N-acetylgalactosaminyltransferase 3 |
|
6 | 7 | |
Q10471 | Polypeptide N-acetylgalactosaminyltransferase 2 |
|
10 | 3 |
|
Q6P9A2 | Polypeptide N-acetylgalactosaminyltransferase 18 |
|
4 | 3 |
|
Q6IS24 | Polypeptide N-acetylgalactosaminyltransferase 17 |
|
3 | 0 |
|
Q8N428 | Polypeptide N-acetylgalactosaminyltransferase 16 |
|
3 | 1 |
|
Q8N3T1 | Polypeptide N-acetylgalactosaminyltransferase 15 |
|
2 | 0 |
|
Q96FL9 | Polypeptide N-acetylgalactosaminyltransferase 14 |
|
3 | 3 |
|
Q8IUC8 | Polypeptide N-acetylgalactosaminyltransferase 13 |
|
3 | 1 |
|
Q8IXK2 | Polypeptide N-acetylgalactosaminyltransferase 12 |
|
4 | 1 |
|
B7Z5G5 | Polypeptide N-acetylgalactosaminyltransferase |
|
1 | 0 |
|
A0A090N7X6 | Polypeptide N-acetylgalactosaminyltransferase |
|
1 | 0 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024